TNF-α blockers in inflammatory bowel diseases: Practical consensus recommendations and a user's guide

被引：0
|
作者：
Pache, Isabelle [1 ]
Rogler, Gerbard [2 ]
Felley, Christian [1 ]
机构：
[1] Univ Lausanne, Dept Gastroenterol & Hepatol, CH-1015 Lausanne, Switzerland
[2] Univ Zurich, Dept Gastroenterol & Hepatol, CH-8006 Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2009年 / 139卷 / 19-20期
关键词：
Crohn's disease; ulcerative colitis; infliximab; adalimumab; certolizumab pegol; SINGLE-CENTER COHORT; NECROSIS-FACTOR ANTAGONISTS; TROUGH SERUM-LEVELS; CROHNS-DISEASE; RANDOMIZED-TRIAL; RHEUMATOID-ARTHRITIS; LOST RESPONSE; ANTI-TNF; OPPORTUNISTIC INFECTIONS; RECEIVING INFLIXIMAB;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 287
页数：10
相关论文
共 50 条
  • [1] TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User's Guide: An Update
    Vulliemoz, Marianne
    Brand, Stephan
    Juillerat, Pascal
    Mottet, Christian
    Ben-Horin, Shomron
    Michetti, Pierre
    [J]. DIGESTION, 2020, 101 (SUPPL 1) : 16 - 26
  • [2] Risk of Vasculitis Associated with Inflammatory Bowel Diseases: Evidence for a Role of TNF-α Blockers
    Terrier, Benjamin
    Beaugerie, Laurent
    Seksik, Philippe
    Sokol, Harry
    Kirchgesner, Julien
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Inflammatory Bowel Disease No increased Risk of Cancer by TNF-α-Blockers
    Weiss, Johannes
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (02):
  • [4] Elevated presepsin levels are a marker of sepsis risk in patients with inflammatory bowel diseases receiving therapy of TNF-α blockers
    Knyazev, O.
    Kagramanova, A.
    Lishchinskaya, A.
    Li, I.
    Noskova, K.
    Fadeeva, N.
    Subbotin, V.
    Demchenko, A.
    Babayan, A.
    Zvyaglova, M.
    Kulakov, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S286 - S287
  • [5] Thioguanine Therapy in Inflammatory Bowel Diseases. A Practical Guide
    Crouwel, Femke
    Simsek, Melek
    Mulder, Chris J. J.
    Buiter, Hans J. C.
    de Boer, Nanne K.
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020, 29 (04) : 637 - 645
  • [6] COMPARISON OF TNF-α INHIBITORS EFFICACY BETWEEN RHEUMATIC DISEASES AND INFLAMMATORY BOWEL DISEASES
    Nuriakhmetova, T.
    Abdulganieva, D.
    Valeeva, I. K.
    Shevnina, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1516 - 1516
  • [7] Functional relevance of soluble TNF-α, transmembrane TNF-α and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseases
    Holtmann, MH
    Schütz, M
    Galle, PR
    Neurath, MF
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2002, 40 (08): : 587 - 600
  • [8] Behcet's Disease, and the Role of TNF-α and TNF-α Blockers
    van der Houwen, Tim
    van Laar, Jan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [9] Evaluation of TNF-α concentration in blood serum of children with inflammatory bowel diseases
    Grzybowska-Chlebowczyk, Urszula
    Wos, Halina
    Gabryel, Bozena
    Wiecek, Sabina
    Kajor, Maciej
    Pajak, Jacek
    [J]. PRZEGLAD GASTROENTEROLOGICZNY, 2008, 3 (03): : 149 - 153
  • [10] Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide
    Guillo, Lucas
    Rabaud, Christian
    Choy, Ernest H.
    D'Amico, Ferdinando
    Danese, Silvio
    Ng, Siew C.
    Peyrin-Biroulet, Laurent
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : 481 - 490
12345